Home-based healthcare markets projected to see significant growth through 2035

The global healthcare landscape is shifting toward home-based care models, driving significant growth in specialized medical markets. The Hospital-at-Home market is projected to expand from $8 billion in 2025 to $35 billion by 2035, representing a compound annual growth rate (CAGR) of 15.9%. This model utilizes remote patient monitoring, AI-driven vital sign tracking, and clinical visits to provide acute-level care in a domestic setting, helping to alleviate hospital bed shortages and rising healthcare costs.

Parallel to this shift, the market for standard pen needles—essential for insulin and other subcutaneous injections—is expected to grow from $1.8 billion in 2025 to $4.03 billion by 2035, with a CAGR of 8.40%. This growth is fueled by the rising prevalence of diabetes and obesity, as well as the increasing use of GLP-1 therapies. As medical care moves from hospitals to homes, there is a heightened demand for user-friendly, disposable injection devices that support long-term chronic disease management and patient self-administration.